On October 9, 2026, the federal government announced new steps to regulate products containing high concentrations of 7-hydroxymitragynine (7-OH), a powerful opioid compound found in kratom leaves.
The announcement comes as concern grows about the safety of these products, which are sold in smoke shops, convenience stores, gas stations, and online. Some of these concentrated kratom and 7-OH products contain much stronger opioid compounds than what is found naturally (in very small amounts) in kratom leaves.
The new federal action does not ban all kratom products. Instead, the Drug Enforcement Administration (DEA) is proposing rules that would treat traditional kratom differently from products containing higher amounts of 7-OH. The changes could affect which products can legally be sold and may also have consequences for manufacturers facing lawsuits over serious injuries and deaths.
What Did the DEA Say About Kratom and 7-OH?
The DEA announced plans to place certain concentrated forms of 7-OH into Schedule I of the federal Controlled Substances Act. Schedule I is the government’s strictest category for controlled substances. It includes drugs such as heroin and LSD that are considered to have a high risk of abuse and no currently accepted medical use.
The announcement followed new recommendations from the 
Department of Health and Human Services (HHS). Federal officials want to focus on products with unusually high amounts of these opioid compounds rather than treating every product made from kratom leaves the same way.
Natural kratom contains only small amounts of 7-OH, but some manufacturers produce highly concentrated versions that can have much stronger effects. The government’s proposal is designed to target these stronger products, not “botanical” kratom.
The new proposal was published in the Federal Register on October 14, 2026. The DEA could begin enforcing the new restrictions as early as November 13, 2026, after a required 30-day waiting period. However, no final date has been announced, and the restrictions will not take effect unless the DEA issues a temporary scheduling order.
Which Kratom and 7-OH Products Would Be Affected?
The proposed rules focus on how much 7-OH a product contains, not simply whether it is labeled as 7-OH or kratom.
Under the new proposal, federal restrictions would apply when the amount of 7-OH exceeds certain limits:
- Solid products: More than 1 milligram 7-OH per gram in tablets, capsules, powders, or other solid products.
- Liquid products: More than 1 milligram 7-OH per milliliter in drinks, shots, or other liquids.
The DEA has also warned that products falling below the proposed limits should not automatically be considered safe. The new rules are meant to identify products for federal drug control, not to establish which 7-OH and kratom products are safe to use.
Does the New Federal Action Make 7-OH Products Illegal?
Not immediately. If the restrictions take effect, products that meet the proposed limits would be treated as Schedule I controlled substances. This would make it illegal for businesses to manufacture, distribute, or sell those products without federal authorization.
However, state laws also play a role. Some states have already restricted or banned certain kratom and 7-OH products. A product may therefore be illegal in one state even if it has not yet been banned under federal law.
Consumers should also understand that being sold in a store does not mean a product has been approved by the Food and Drug Administration (FDA). The FDA has not approved any 7-OH products for treating pain, anxiety, addiction, or any other medical condition.
What if I Use Kratom or 7-OH for Pain or Anxiety?
Many people use kratom to manage chronic pain, anxiety, or other conditions, with some reporting that it has significantly improved their quality of life. These experiences should not be dismissed.
However, there is an important difference between traditional kratom and 
products containing highly concentrated or added 7-OH.These stronger products can have powerful opioid effects and carry a significant risk of abuse, dependence, and overdose. Given the devastating impact of the opioid crisis, these risks should be taken seriously. People seeking relief from chronic pain or anxiety should work with a qualified healthcare provider rather than relying on unregulated products that may contain dangerously high levels of opioid compounds.
Additionally, the current concern is not with people seeking relief, but with manufacturers that put consumers at risk by selling potentially dangerous products that have not been approved by the FDA for medical use and may lack adequate warnings about their risks.
What Does This Mean for Kratom and 7-OH Manufacturers?
The DEA’s announcement puts more attention on companies that make and sell concentrated kratom and 7-OH products. If adopted, the new rules will make it increasingly important for manufacturers to test their products to determine whether they contain too much 7-OH to be legally sold.
Manufacturers that violate the proposed federal restrictions could face serious criminal penalties, including substantial fines, product seizures, and even prison sentences for those responsible. They may also face civil lawsuits if their products cause harm.
Could the DEA’s New Action Affect Lawsuits?
The new federal action could become important in future lawsuits involving concentrated 7-OH products. The DEA’s findings highlight the serious risks associated with concentrated 7-OH products and could strengthen future lawsuits against manufacturers that failed to adequately warn consumers about those dangers.
However, the DEA’s findings will not automatically prove that a manufacturer did something wrong. Each case must be evaluated based on the product involved, how it was sold, what warnings were provided, and whether it contributed to the person’s injuries.
Evidence can make a major difference in these cases. Medical records can document serious injuries, while treatment records from addiction or rehabilitation programs may help establish the extent of a person’s dependence and efforts to recover. In cases involving a death, autopsy and toxicology reports may also provide important information.
Have Kratom and 7-OH Manufacturers Already Faced Lawsuits?
Yes. Kratom manufacturers and sellers have already faced lawsuits involving serious injuries, deaths, and claims that their products were marketed without adequate warnings.
- In one Florida case, a jury awarded approximately $11 million to the family of a 30-year-old mother who died from acute mitragynine intoxication. The lawsuit involved Grow LLC, doing business as The Kratom Distro. The family argued that the company sold kratom as a natural supplement without properly warning consumers about its dangers.
- In Washington, a jury awarded $2.5 million to the family of a man who died after using kratom. The lawsuit involved Kratom Divine and raised questions about the safety of the products and the warnings provided to customers.
- A class action involving Feel Free, a drink containing kratom and kava, resulted in an $8.75 million settlement. Consumers claimed the product’s marketing did not adequately explain its risks, including the possibility of addiction.
These cases involved different products and circumstances. Not all of them involved concentrated 7-OH, and the results do not mean every kratom product is dangerous or defective. However, they do show that companies selling kratom products can face serious legal consequences when people are harmed and the products are alleged to have been improperly marketed or labeled.
Schlesinger Law Offices is Investigating Concentrated Kratom and 7-OH Injury Claims
Schlesinger Law Offices is investigating serious injuries and wrongful deaths involving concentrated kratom extracts and products containing added or concentrated 7-OH. These cases include fatal overdoses, respiratory arrest, serious seizures, liver failure, major heart problems, and severe addiction requiring inpatient treatment.
To learn more about these substances and their potential health effects, read our related article, Kratom and 7-OH: What Are the Risks?
If you or someone you love suffered a serious injury after using a concentrated kratom or 7-OH product, contact Schlesinger Law Offices for a free, confidential case review. Our attorneys can review what happened, investigate the product involved, and help determine whether you may have a legal claim.